The specific RET mutation also predicts phenotypic characteristics such as aggressiveness of medullary thyroid carcinoma and presence of other endocrinopathies, so is important in clinical management; however, other factors, such as older age at onset and higher tumor stage at diagnosis, may be more predictive of disease aggressiveness (2).